
Leucovorin tablets/Capsule
Form: Tablet/Capsules
Strength: 15 mg, 50 mg
Reference Brands: Folvite(US & EU)
Category: Blood Disorder
Leucovorin tablets, marketed as Folvite, are approved in both the US by the FDA and in the EU via EMA for folate supplementation, chemotherapy support, and toxicity mitigation. Regulatory approval requires a comprehensive dossier including manufacturing details, clinical efficacy, safety data, and pharmacovigilance plans. In the US, FDA review involves detailed assessment of clinical and manufacturing information, while the EMA ensures compliance with regional standards. For expert guidance on dossier preparation, regulatory strategies, and market access, visit PharmaTradz. Ensuring regional compliance is vital for the safe and effective use of leucovorin tablets worldwide, supporting optimal patient outcomes in oncology and folate deficiency management.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Anti-Inhibitor Coagulant Complex (AICC) Lyophilized Powder
Strength: 500 units, 1000 units, and 2500 units
Form: Lyophilized Powder (Reconstituted for IV infusion)
Reference Brands: FEIBA(US)
View Details Get EnquiryProthrombin Complex Concentrate (PCC) injection
Strength: 250 IU to 300 IU
Form: Injection
Reference Brands: Kcentra (4-factor PCC), Bebulin VH (3-factor PCC)(US)
View Details Get EnquiryMesna Injection
Strength: 100 mg/mL
Form: Injection
Reference Brands: Mesnex(US)
View Details Get EnquiryPegfilgrastim injection
Strength: 6 mg per single-use syringe
Form: Injection
Reference Brands: Neulasta, Pelgraz(US)
View Details Get Enquiry